Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Diabetic Foot Ulcers (NCT07039396)

🧪 Interventions in This Study

• NeoThelium FT (HCT/P 361) (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (3 Sites)

• MedCentris of Alexandria — Alexandria, Louisiana
• MedCentris of Leesville — Leesville, Louisiana
• MedCentris of Many — Many, Louisiana

📞 Contact the Study Coordinator

Phone: (986) 629-4013

Email: info@sygnola.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Diabetic Foot Ulcer

• Omega3 Wound Fish Skin Graft in the Treatment of DFUs — Coconut Creek, Florida
• At-Home Exercise Study for Veterans With Healed Diabetic Foot Ulcers — Baltimore, Maryland
• A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot — San Francisco, California
• Efficacy of ProgenaMatrix™ in the Management of DFUs — Puyallup, Washington
• Clinical Utility of an Amniotic Membrane Allograft for Diabetic Foot Ulcer Wound Management — Palm Springs, California
• NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers — Phoenix, Arizona

Explore by condition: All Diabetic Foot Ulcer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.